Manufacturing

Yet another Lupin plant in India is in hot water with the FDA

A fourth Lupin manufacturing facility in India has been slapped by the FDA with a Form 483 notice, citing eight issues at its API plant in Mandideep.

Kevin Dunleavy Nov 28, 2022 11:22am

With boost from Romania, Stada breaks ground on $50M plant

Nov 28, 2022 10:05am

BMS, generics companies face new suit over Revlimid 'monopoly'

Nov 22, 2022 11:38am

Fujifilm continues expansion with $188M slotted for cell culture

Nov 22, 2022 10:06am

Rentschler and Oxford are the latest companies swapping out CEOs

Nov 22, 2022 9:00am

After a quiet spell, WuXi Bio is back with another big expansion

Nov 21, 2022 10:55am